GPAS 2025: Shaping the Future of Bleeding Disorder Care
The World Federation of Hemophilia (WFH) recently shared an insightful post on X:
”At GPAS 2025, global experts explored the evolving treatment landscape for bleeding disorders—highlighting innovations in hemophilia and VWD care, and addressing challenges in access and reimbursement. A timely look at what’s ahead in care.”
At GPAS 2025, leading global experts Jamie O’Hara, Alok Srivastava, Nathan Connell and Cedric Hermans convened to discuss the rapidly evolving treatment landscape for bleeding disorders.
Sessions spotlighted innovation in hemophilia and von Willebrand disease (VWD) care, including novel therapeutics, personalized medicine, and gene-based approaches.
Critical dialogue also addressed ongoing challenges in access, affordability, and reimbursement.
The meeting offered a timely and forward-looking perspective on the future of equitable care delivery!
Find more footage from the webinar in the gallery.
Hemostasis Today, your daily update on the World of Hemophilia.
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women